BeOne Medicines Insider Trading Continues: Executive's Stock Sales Top $31M in Q2 2025

Rhea-AI Filing Summary

BeOne Medicines Ltd. has filed a Form 144 notice for the proposed sale of 2,007 American Depositary Shares (ADS) through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $516,822.57 and are planned to be sold on the NASDAQ around June 24, 2025.

The securities were originally acquired as Restricted Stock Units from the issuer on June 15, 2025. The filing also discloses significant recent trading activity by XIAODONG WANG through a 10b5-1 trading plan, including:

• June 10, 2025: 41,760 ADS sold for $10,975,317.26
• May 13, 2025: 41,760 ADS sold for $9,333,272.30
• April 14, 2025: 41,760 ADS sold for $10,133,594.35

The total outstanding shares of the company are 56,964,739. This Form 144 represents the declaration of intention to sell securities acquired through RSUs, following a pattern of systematic sales through an established 10b5-1 trading plan.

Positive

• None.

Negative

• Significant insider selling pattern: Executive has sold 125,280 ADS shares over 3 months totaling approximately $30.4M through 10b5-1 plan sales
• Current Form 144 filing indicates intention to sell additional 2,007 ADS shares worth $516,823, continuing the selling trend

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADS	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2007	516822.57	56964739	06/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADS	06/15/2025	Restricted Stock Units	Issuer			2007	06/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for XIAODONG WANG Aeschengraben 27, 21st Floor Basel V8 4051	ADS	06/10/2025	41760	10975317.26
10b5-1 Sales for XIAODONG WANG Aeschengraben 27, 21st Floor Basel V8 4051	ADS	05/13/2025	41760	9333272.30
10b5-1 Sales for XIAODONG WANG Aeschengraben 27, 21st Floor Basel V8 4051	ADS	04/14/2025	41760	10133594.35

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ONC (BeOne Medicines) shares are being sold by the insider according to the June 2025 Form 144?

According to the Form 144 filing, the insider plans to sell 2,007 American Depositary Shares (ADS) of ONC with an aggregate market value of $516,822.57 through Morgan Stanley Smith Barney LLC.

What is the trading history of ONC insider sales in the past 3 months before June 2025?

The filing shows that XIAODONG WANG made three 10b5-1 planned sales: 41,760 ADS for $10.98M on June 10, 2025; 41,760 ADS for $9.33M on May 13, 2025; and 41,760 ADS for $10.13M on April 14, 2025.

How many total shares of ONC were outstanding as of June 2025?

According to the Form 144 filing, ONC (BeOne Medicines) had 56,964,739 shares outstanding at the time of the filing.

How did the insider acquire the ONC shares being sold?

The shares being sold were acquired through Restricted Stock Units (RSUs) from the issuer on June 15, 2025, just prior to the planned sale date of June 24, 2025.